We found a tendency toward higher TREM2 mRNA expression in APOEε4 carriers vs. non-carriers after acute M1-macrophage differentiation, which is consistent with some studies of AD patients (Casati et al. 2018; Mori et al. 2015). The gene discussed is TREM2; the disease is Alzheimer disease.